Chimeric Antigen Receptor News and Research

RSS

New technology provides clearer picture to clinicians treating gynecological cancer

New technology developed at Western University is providing an improved way for radiation oncologists to deliver treatment to women with gynecological cancers, including vaginal, cervical and uterine cancer.

9 Apr 2019

New app can help fill the massive gap in reporting hate incidents

The Federal Bureau of Investigation is responsible for tracking hate crimes across the country, but the data are notoriously unreliable.

9 Apr 2019

Scientists visualize immune cells fighting blood cancer for the first time

When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease.

8 Apr 2019

A gene regulatory multi-tool plays key role in unjamming the genome after DNA damage

A protein complex that is involved in nearly every step in the regulatory control of gene expression in cells has now been shown also to play a key role in clearing potential traffic jams in the production of RNA.

5 Apr 2019

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.

3 Apr 2019

Finding homeless patients a place to heal

After they amputated the second toe on John Trumbla's right foot last summer, doctors sent him to a nursing home because he still needed medical care — but not necessarily a hospital bed.

3 Apr 2019

Long-commutes during pregnancy linked to higher risk for adverse birth outcomes

In a study published in Economics & Human Biology researchers from Lehigh University and the University of Wisconsin-Madison found that pregnant women who commute long-distance to work have an increased risk of adverse birth outcomes, including having babies born at a low-birth weight.

1 Apr 2019

Tumor biomarker EpCAM shown to be promising target for cancer immunotherapy

Researchers have shown that cancer immunotherapy targeting the tumor biomarker epithelial cell adhesion molecule is safe and nontoxic in mice and can significantly delay tumor formation and growth.

28 Mar 2019

Purdue engineers develop tiny glutamate sensors for spinal cord injuries

Your chances of getting a nasty migraine increase following a spinal cord injury, thanks to a chemical messenger in the brain that spikes to toxic levels, past studies have suggested.

28 Mar 2019

Heating tumors during CAR T-cell therapy can enhance treatment's success, study suggests

A preclinical study led by scientists at the UCLA Jonsson Comprehensive Cancer suggests that heating solid tumors during CAR T-cell therapy can enhance the treatment's success.

28 Mar 2019

Study sheds light on why some people hear 'hear' silent flashes or movement

A synaesthesia-like effect in which people 'hear' silent flashes or movement, such as in popular 'noisy GIFs' and memes, could be due to a reduction of inhibition of signals that travel between visual and auditory areas of the brain, according to a new study led by researchers at City, University of London.

28 Mar 2019

Impact of legalizing cannabis on the opioid crisis

Legislators believe that the passage of cannabis access laws will play a significant role in addressing the ongoing opioid crisis.

26 Mar 2019

Children more likely to suffer PTSD when they think negatively about their trauma

Children are more likely to suffer Post Traumatic Stress Disorder if they think their reaction to traumatic events is not 'normal' - according to new research from the University of East Anglia.

26 Mar 2019

She was dancing on the roof and talking gibberish. A special kind of ER helped her.

For decades, hospitals have strained to accommodate patients in psychiatric crisis in emergency rooms.

25 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year's American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 - April 3, 2019.

22 Mar 2019

Merck to collaborate with GenScript for plasmid and virus manufacturing in China

Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.

From Merck 20 Mar 2019

Trigger warnings have minimal impact on how people respond to content, shows research

Trigger warnings that alert people to potentially sensitive content are increasingly popular, especially on college campuses, but research suggests that they have minimal impact on how people actually respond to content.

20 Mar 2019

Scientists identify brain circuit responsible for cocaine-seeking behavior during relapse

Approximately 1.5 million Americans use cocaine in a given year, according to the National Institute on Drug Abuse. Many are repeat users. Unfortunately, there are currently no FDA-approved medicinal treatments for cocaine addiction.

19 Mar 2019

Antibody-drug conjugate effectively targets surface protein in childhood neuroblastomas

Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells.

14 Mar 2019

Chimeric Antigen Receptor News and Research

New technology provides clearer picture to clinicians treating gynecological cancer

New app can help fill the massive gap in reporting hate incidents

Scientists visualize immune cells fighting blood cancer for the first time

A gene regulatory multi-tool plays key role in unjamming the genome after DNA damage

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

Finding homeless patients a place to heal

Long-commutes during pregnancy linked to higher risk for adverse birth outcomes

Tumor biomarker EpCAM shown to be promising target for cancer immunotherapy

Purdue engineers develop tiny glutamate sensors for spinal cord injuries

Heating tumors during CAR T-cell therapy can enhance treatment's success, study suggests

Study sheds light on why some people hear 'hear' silent flashes or movement

Impact of legalizing cannabis on the opioid crisis

Children more likely to suffer PTSD when they think negatively about their trauma

She was dancing on the roof and talking gibberish. A special kind of ER helped her.

City of Hope exhibits current studies and data on cancer therapies at AACR

Ludwig scientists to share advances in cancer research at AACR Annual Meeting 2019

Merck to collaborate with GenScript for plasmid and virus manufacturing in China

Trigger warnings have minimal impact on how people respond to content, shows research

Scientists identify brain circuit responsible for cocaine-seeking behavior during relapse

Antibody-drug conjugate effectively targets surface protein in childhood neuroblastomas

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®